Investors / United States / Cure Ventures
Cure Ventures
Venture capital · Boston, MA, United States · North America
Cure Ventures is a life sciences venture capital firm founded in 2021 that focuses on de novo company formation around curative technologies. It invests at seed to de-risk science, uses genetic validation, and embeds its own operators to work alongside founders.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechtherapeuticsdrug discoverycompany formationgenetics
Your fit with Cure Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsCure Ventures lists 10 checked portfolio companies on its own site and is named in 1 funding round, 1 of them as lead. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside 1843 Capital, 8VC and AN Venture Partners.
Counts come from funding rounds that name Cure Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Cure Ventures' whole history. Rounds on record name 1 company; its own site lists 10. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 100% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 23th | 10 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 77th | 10% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 20th | 1 country |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| 1843 Capital | 1 |
| 8VC | 1 |
| AN Venture Partners | 1 |
| ARCH Venture Partners | 1 |
| BrightEdge | 1 |
| Canaan | 1 |
| Capitoria | 1 |
| Catalio Capital Management | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers10100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Cure Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its siteRecent portfolio activity
when companies last raised with Cure Ventures| Date | Company | Stage |
|---|---|---|
| 21 Apr 2026 | Series A Led |
Round details for Cure Ventures
Amounts, full round histories and every co-investor in Cure Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
10 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Aevum is pioneering the discovery and development of therapeutic molecules derived from exercise to treat disease. | Healthcare & Biotech | Portfolio page | ||
| Clasp Therapeutics is dedicated to transforming the lives of patients everywhere by mastering the discovery, development and delivery of off-the-shelf precision immunotherapies | Healthcare & Biotech | Portfolio page | ||
| Kobuk Therapeutics is developing a biologics platform to address autoimmune diseases | Healthcare & Biotech | Portfolio page | ||
| Permeasis Therapeutics is building a platform to deliver biologically active macromolecules inside cells. | Healthcare & Biotech | Portfolio page | ||
| Recuro Health provides virtual healthcare services, including primary care, urgent care, and behavioral health services, to its members | Healthcare & Biotech | Portfolio page | ||
| Tasca Therapeutics develops new medicines to treat cancer patients using a unique drug discovery platform | Healthcare & Biotech | Portfolio page | ||
| Tortugas Neuroscience develops drugs for neurology and neuropsychiatry | Healthcare & Biotech | Apr 2026Series A | Page + round | |
| Triton Therapeutics is a clinical-stage company developing first-in-class medicines for autoimmune and other immune-mediated inflammatory diseases. | Healthcare & Biotech | Portfolio page | ||
| XenImmune is a company that applies the biology of organ transplant hyperacute rejection to fight cancer. | Healthcare & Biotech | Portfolio page | ||
| Crosslink Therapeutics is developing biologics for the treatment of cancer | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- curevc.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 21 Apr 2026
- Companies checked
- 10
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Cure Ventures' profile as data
Pull Cure Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/curevc.com
# also
GET /v1/firms/curevc.com/portfolio
GET /v1/firms/curevc.com/coinvestors
GET /v1/firms/curevc.com/news